Advancing new drug therapies for unmet medical needs

Advancing new drug therapies for unmet medical needs 2017-08-21T11:43:59+00:00

Dimerix Limited is a clinical stage biotechnology company that is listed on the Australian Stock Exchange (ASX:DXB)

Our vision is to positively improve human health by creating safe and effective new treatments for patients with unmet medical needs

Recent news and media

ASX Announcement – Results of AGM

The results from the Dimerix 2017 AGM are available here.

ASX Announcement – AGM Presentation

The Dimerix AGM is today, 19 October 2017. The presentation that CEO Kathy Harrison will use is available here. NOTE: This [...]

ASX Announcement – Dimerix appoints Medical Advisory Board

We are very pleased to announce the appointment of a Medical Advisory Board (MAB) to help guide the Company’s DMX-200 clinical [...]